Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects

被引:103
|
作者
Moriya, Y
Nakamura, T
Horinouchi, M
Sakaeda, T
Tamura, T
Aoyama, N
Shirakawa, T
Gotoh, A
Fujimoto, S
Matsuo, M
Kasuga, M
Okumura, K [1 ]
机构
[1] Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 650, Japan
[2] Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, Kyoto 6078414, Japan
[3] Kobe Univ, Sch Med, Dept Endoscopy, Kobe, Hyogo, Japan
[4] Kobe Univ, Sch Med, Dept Clin Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan
[5] Kobe Univ, Sch Med, Int Ctr Med Res, Chuo Ku, Kobe, Hyogo 6500017, Japan
[6] Kobe Univ, Grad Sch Med, Fac Med,Div Diabet Digest & Kidney Dis, Dept Clin Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan
[7] Kobe Univ, Grad Sch Med, Dept Organ Therapeut, Fac Med,Div Urol,Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
P-glycoprotein; multidrug resistance-associated protein; genetic polymorphism; gene expression; duodenal enterocyte;
D O I
10.1248/bpb.25.1356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, we examined whether polymorphisms in the ATP-binding cassette (ABC) transporter genes, MDR1, MRP1 and MRP2, were associated with their respective mRNA expression levels in duodenal enterocytes of 13 healthy Japanese volunteers. MDR1 genotypes of T-129C, G2677(A,T) and C3435T, MRP1 genotypes of G128C, C218T, G2168A and G3173A, and MRP2 genotypes of C-24T, G1249A, C2302T, C2366T and G4348A were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or direct sequencing. Mutations T-129C, G2677(A,T) and C3435T of MDR1 gene were found at allele frequencies of 2/26, 16/26 and 12/26, respectively. Mutations G2168A of the MRP1 gene and C-24T of the MRP2 gene were also found at allele frequencies of 1/26 and 6/26, respectively, whereas other mutations were not detected in MRP1 and MRP2 genes. The relative concentrations (mean+/-S.E.) of MDR1 mPNA to villin mRNA were 0.38+/-0.15, 0.56+/-0.14 and 1.13+/-0.42 in the subjects with C/C-3435, C/T-3435 and T/T-3435, respectively, which supported the lower serum concentrations of digoxin after single oral administration in the subjects with the mutant T-allele at position 3435. Genetic collaboration between positions 3435 and 2677 was suggested, and those in G/G(2677), G/(A,T)(2677) and T/(A,T)(2677) were 0.16+/-0.05, 1.10+/-0.40, and 0.63+/-0.16, respectively (p = 0.107). However, there was no remarkable effect of the G2168A of the MRP1 gene or of C-24T of the MRP2 gene on the relative MRP1 or MRP2 mRNA concentrations, respectively.
引用
收藏
页码:1356 / 1359
页数:4
相关论文
共 50 条
  • [41] Significance of the expression of MRP1 and MRP2 in peripheral blood mononuclear cells of children with intractable epilepsy
    Liu, Xiaoming
    Yue, Xuan
    Chen, Shengzhi
    Chen, Jiao
    Li, Rui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1784 - 1788
  • [42] mRNA expression levels of MDR1, MRP, GSTπ and GSTμ in acute leukemia in Indian patients.
    Gurbuxani, S
    Bhargava, M
    Sazawal, S
    Raina, V
    Arya, LS
    Marie, JP
    BLOOD, 1999, 94 (10) : 278A - 279A
  • [43] Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte
    Takebayashi, Y
    Nakayama, K
    Fujioka, T
    Kanzaki, A
    Mutho, M
    Uchida, T
    Miyazaki, K
    Ito, M
    Fukumoto, M
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (04) : 397 - 400
  • [44] The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma
    Soini, Y
    Järvinen, K
    Kaarteenaho-Wiik, R
    Kinnula, V
    ANNALS OF ONCOLOGY, 2001, 12 (09) : 1239 - 1245
  • [45] Site and age-dependent expression of MDR1, BCRP and MRP2 in the gastrointestinal tract of rats
    MacLean, C
    Reichel, A
    Mertsch, K
    Fricker, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 17 - 17
  • [46] Reduction of MDR1, MRP1 and BCRP expression in Crohn's disease: a role in disease pathogenesis?
    Mlakar, Ana Savic
    Babic, Zarko
    Troskot, Branko
    Jergovic, Mladen
    Parcina, Valerija Vojvoda
    Mihaljevic, Zeljko
    Bendelja, Kreso
    PERIODICUM BIOLOGORUM, 2015, 117 (03) : 347 - 355
  • [47] Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma
    Friedrich, RE
    Punke, C
    Reymann, A
    IN VIVO, 2004, 18 (02): : 133 - 147
  • [48] High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease
    Ros, JE
    Libbrecht, L
    Geuken, M
    Jansen, PLM
    Roskams, TAD
    JOURNAL OF PATHOLOGY, 2003, 200 (05): : 553 - 560
  • [49] Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver
    Albermann, N
    Schmitz-Winnenthal, FH
    Z'graggen, K
    Volk, C
    Hoffmann, MM
    Haefeli, WE
    Weiss, J
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (06) : 949 - 958
  • [50] Expression of multidrug transporters MRP1 and MRP2 during epileptogenesis in a rat model for temporal lobe epilepsy
    van Vliet, EA
    Aronica, E
    Gorter, JA
    EPILEPSIA, 2004, 45 : 205 - 206